Who invested in Antiva Biosciences

2 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$75Mraised across 2 rounds since 2017, from 2 sources

$22MSeries C$53MSeries E

Latest round: Series E, $53MApr 2023
Step-upi: 2.4×
Investors: 9

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2017201820192020202120222023

$22MSeries C$53MSeries E

First round: Series C, $22M
Biggest round: $53M
Between rounds: 6 years

The rounds

Apr 2023
Series E$53M4 new
Source recordedSEC filing: $27M sold, first sale Apr 2023
Mar 2017
Series C$22M5 new
- Canaan
- Sofinnova Investments
- Alexandria Real Estate Equities
- Osage University Partners
- Brace Pharma Capital/ NS
Also list them on their own siteParatus Investment
Reported by FinSMEsSEC filing: $11M sold, first sale Feb 2017

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series C2017Series E2023

Sofinnova Investments

Mana Ventures

Alexandria Real Estate Equities

Osage University PartnersBrace Pharma Capital/ NS

Everyone who backed them

GaingelsPrivate equity1round

Google VenturesCorporate VC1round

CanaanVC firm1round

Hill House CapitalFamily office1round

Sofinnova InvestmentsVC firm1round

Mana VenturesVC firm1round

Alexandria Real Estate EquitiesVC firm1round

Osage University PartnersVC firm1round

Brace Pharma Capital/ NSno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Antiva Biosciences as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Adjuvant CapitalVC firmPer its own site

Brace PharmaVC firmPer its own site

Paratus InvestmentPrivate equity2017, per its site

Quick answers about Antiva Biosciences

Who invested in Antiva Biosciences?

Antiva Biosciences's investors include Gaingels, Google Ventures, Canaan, Hill House Capital and Sofinnova Investments, and 4 more on record.

How much has Antiva Biosciences raised?

Antiva Biosciences has raised $75M across 2 rounds since 2017.

When did Antiva Biosciences last raise?

Antiva Biosciences's most recent round was a Series E of $53M in Apr 2023.

What was Antiva Biosciences's biggest round?

Its most recent round, $53M in Apr 2023, is also its largest on record.

Who backed Antiva Biosciences first?

Antiva Biosciences's first round on record, in Mar 2017, was backed by Canaan, Sofinnova Investments and Alexandria Real Estate Equities and 2 others.